Technavio analyzes that the Transdermal Patches Market is expected to grow at a CAGR of 5.65% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 2.00 billion.There are various factors that contribute to the growth of the market. The transdermal patches market is experiencing significant growth due to the increasing preference for non-invasive drug delivery methods. Patients are increasingly seeking alternatives to traditional methods such as injections and oral medications, which can be inconvenient or come with unwanted side effects. Transdermal patches offer a discreet, convenient, and effective solution for administering medications through the skin, making them an attractive option for various therapeutic applications. The market is expected to continue expanding as technology advances and new applications for transdermal patches are discovered.
Transdermal patches represent a groundbreaking innovation in pain management, providing a targeted and convenient solution for various types of pain. These patches function by delivering medications directly through the skin, ensuring systemic absorption and extended relief. Key therapeutic categories in transdermal patches include opioids, NSAIDs, lidocaine, and other analgesics. The global market for transdermal patches in pain management is experiencing significant growth, fueled by the escalating prevalence of chronic pain conditions, such as arthritis, neuropathic pain, and musculoskeletal disorders, as well as the aging population and increasing healthcare expenditures. The multi-layer drug-in-adhesive segment is a notable market trend, offering enhanced drug delivery and adhesion properties.
Know which region is leading the market growth by requesting a sample report
Transdermal Patches Market Segmentation
As per our research findings, here are some of the key competitors that are leading the industry
Find out what is trending in the market by accessing the free PDF report
Transdermal patches, a non-invasive method for medication delivery, have gained popularity in managing chronic illnesses such as diabetes, hypertension, and pain-related conditions. These patches, which use adhesive technology to adhere to the skin, allow for controlled dosing and prolonged therapeutic effects. Technological advancements have led to the development of electronic and mechanical transdermal patches, offering alternatives to traditional injections. The opioid epidemic has increased the demand for non-addictive pain management techniques, making transdermal patches an attractive option. Analgesic patches, which deliver medication through the skin directly into the bloodstream, offer a more convenient and cost-effective solution compared to frequent healthcare facility visits and medication failures. Chronic diseases, particularly those affecting the elderly population, can benefit greatly from the use of transdermal patches, ensuring consistent medication adherence and improved patient outcomes.
The Transdermal Patches Market is a significant segment within the global Pharmaceuticals Industry, encompassing entities involved in Research and Development (R&D) or manufacturing of analgesic patches and other transdermal medications. According to Technavio, the Pharmaceuticals Market, which includes companies producing generic and non-generic drugs, veterinary drugs, and associated equipment and services, is a key constituent of the broader Healthcare Industry. The expansion of the Pharmaceuticals Market will be influenced by several factors, including the increasing global geriatric population, technological advancements in patch design and application, and the rising costs of traditional injection-based pain management techniques. These factors contribute to the growing demand for effective, cost-efficient, and convenient pain management solutions, such as transdermal patches, in the healthcare landscape.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
